Top Story

FDA approves dulaglutide to treat type 2 diabetes

September 18, 2014

The FDA today approved dulaglutide as a once-weekly injection for patients with type 2 diabetes to improve glycemic control in conjunction with diet and exercise.

Dulaglutide, a glucagon-like peptide-1 receptor to be known as Trulicity (Eli Lilly), has been studied as a solo treatment and in conjunction with other therapies such as metformin, sulfonylurea and others. In the most recent study published, dulaglutide was shown comparable to liraglutide (Victoza, Novo Nordisk) in controlling HbA1c and hypoglycemia. The most common side effects were nausea, diarrhea, vomiting, abdominal pain and decreased appetite.

Meeting News Coverage

Gestational diabetes increased type 2 diabetes, CV risk

September 18, 2014
The risk for type 2 diabetes and cardiovascular diseases is increased with pregnancies complicated by gestational diabetes that end in stillbirth, according to research…
Meeting News Coverage

Higher plasma levels linked to CV complications in type 1 diabetes

September 18, 2014
Cardiovascular complications are associated with higher plasma levels in patients with type 1 diabetes, according to a presenter at the 50th European Association for the…
FDA News

Eylea earns breakthrough therapy designation from FDA

September 18, 2014
The U.S. Food and Drug Administration has granted breakthrough therapy designation to Eylea for the treatment of diabetic retinopathy in patients with diabetic macular…
More News Headlines »
Imaging Analysis Publication Exclusive
figure

Looking at an unusual case of hypercalcemia

Endocrine Today, August 2014
Stephanie L. Lee, MD, PhD, ECNU
A 58-year-old female was readmitted for fevers and hypotension. Her previous medical history was significant for…
More »
Blog

Darier's sign and osteoporosis

November 27, 2013
Melissa, a 61-year-old woman, was referred for evaluation and management of osteoporosis. She was “petite,”…
More »
Meeting News Coverage Video
figure

Video: Ardis Hoven, MD, explains which changes to the ACA will help physicians most

August 8, 2014
After speaking in an expert panel at the American Association of Diabetes Educators Annual Meeting, Ardis Hoven
More »